Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 AUD | +9.91% |
|
+5.17% | +197.56% |
May. 29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
May. 27 | Dimerix Signs License Deal for Kidney Disease Medication in the Middle East | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
204M | - | - | - | - | - | |
51.07B | - | |||||
38.78B | ||||||
38.61B | ||||||
27.32B | ||||||
26.35B |
- Stock Market
- Equities
- DXB Stock
- Charts Dimerix Limited
- Sector Chart